Stock Alert: Cassava Sciences Up 13%

(RTTNews) - Cassava Sciences, Inc. (SAVA) shares are gaining more than 15 percent on Friday morning. Thursday, Cantor Fitzgerald initiated coverage of Cassava at 'Overweight' with a price target of $24.

The stock had closed at $8.83 yesterday. The shares are currently at $9.97, up 13.08 percent from its previous close. The shares have traded in a range of $1.21 to $12.68 on average volume of 6,949,456.

Earlier in September, the biotech company had announced a statistically significant improvement in Alzheimer's patients with Sumifilam 50 mg or 100 mg twice daily for 28 days. The Phase II trial showed improvements in biomarkers of the degenerative disease compared to the placebo group.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More